Healthcare -
Biotechnology - NASDAQ - US
$ 19.335
3.19 %
$ 2.43 B
Market Cap
-10.61
P/E
APLS - OPERATING INCOME
Operating Income APLS - Apellis Pharmaceuticals, Inc.
-165 M
LAST VALUE
47.33%
2 YEAR CAGR
10.55%
5 YEAR CAGR
-30.75%
10 YEAR CAGR